Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03096197 · ClinicalTrials.gov registry record · NA
Exoskeleton and Spinal Cord Stimulation for SCI
A NA study of Spinal Cord Injury and Muscle Spasticity, sponsored by Kessler Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03096197: Recruiting NA study of Spinal Cord Injury and Muscle Spasticity, sponsored by Kessler Foundation.
NCT03096197 is a NA study of Spinal Cord Injury and Muscle Spasticity that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 24 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03096197, a NA study of Spinal Cord Injury and Muscle Spasticity, is actively recruiting participants, sponsored by Kessler Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of this project is to assess the effect of combining transcutaneous lumbosacral stimulation (TLS) during Exoskeleton Assisted Walking (EAW) compared to EAW alone without stimulation on walking recovery.
Primary Outcome
Participants undergoing EAW+TLS intervention will walk significantly further than those receiving EAW alone.
Conditions Studied
Interventions
- DEVICE Exoskeleton-Assisted Walking
- DEVICE Transcutaneous Lumbosacral Stimulation (TLS)
Study Locations (1)
New Jersey
- Kessler Foundation - West Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-03-30 |
| Est. Completion | 2029-09 |
| Phase | NA |
What NCT03096197 shows while recruiting
NCT03096197 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (72% lower).
The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 2 interventions - of which Exoskeleton-Assisted Walking is the first listed.
NCT03096197 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03096197 about?
NCT03096197 is a clinical study titled "Exoskeleton and Spinal Cord Stimulation for SCI". The overall aim of this project is to assess the effect of combining transcutaneous lumbosacral stimulation (TLS) during Exoskeleton Assisted Walking (EAW) compared to EAW alone without stimulation on walking recovery.
What is the current status of trial NCT03096197?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2017-03-30. Estimated completion is 2029-09.
What conditions does trial NCT03096197 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Muscle Spasticity, Ambulation Difficulty.
What interventions are being tested in trial NCT03096197?
The interventions under investigation include: Exoskeleton-Assisted Walking (DEVICE), Transcutaneous Lumbosacral Stimulation (TLS) (DEVICE).
Who is sponsoring clinical trial NCT03096197?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03096197 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03096197's enrollment target sits among peer trials
24 51st of 99 higher than 48 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
VR Mindfulness Training for Veterans With SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- NCT03437005 · 24 participants · Phase 1
Alternation in the Human Microbiome With Commonly Used Topical Medications
- NCT03452202 · 24 participants · NA
Using tDCS in Speech-based Stroke Rehabilitation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI